|
KRTX
|
Karuna Therapeutics, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.30%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.30%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.29%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
0.29%
|
US
|
NASDAQ
|
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.25%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.25%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
ABCL
|
AbCellera Biologics Inc.
|
0.23%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
0.22%
|
US
|
NASDAQ
|
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
TWST
|
Twist Bioscience Corporation
|
0.20%
|
US
|
NASDAQ
|
|
LEGN
|
Legend Biotech Corporation
|
0.20%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
0.20%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.19%
|
US
|
NASDAQ
|